ORPHA:99829
Yellow fever
Also known as: Bronze John · YF · Yellow Jack
Publications
70,238
Trials
52
Interventional, condition-specific
Researchers
1,572
Distinct authors in sample
Gene link
—
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
Yellow fever (YF), caused by YF virus, is a zoonotic disease characterized by fever and constitutional symptoms, with the potential to progress to severe and fatal viral hemorrhagic fever with shock and multi-organ system failure.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0020502
- MeSH:D015004
- UMLS:C0043395
- NCIT:C35547
Additional Mondo synonyms (6)
Yellow fever Virus infection · Yellow fever virus caused disease or disorder · Yellow fever virus disease or disorder · Yellow fever virus infectious disease · bronze John · sylvatic yellow fever
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
70,238 matched papers (34,395 in last 10 years) Source
- Phenotype characterisedPresent
49 HPO annotations (e.g. Hematemesis; Headache; Arthralgia) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
52 matched on ClinicalTrials.gov (8 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
49
Associated phenotypes · MONDO:0020502
- Hematemesis
- Headache
- Arthralgia
- Elevated circulating creatine kinase activity
- Elevated circulating creatinine concentration
Showing 5 of 49 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
70,238
70,238 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
70,238 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
34,395 in the last 10 years · low confidence
Phrase hits: 70,238 · MeSH hits: 3,035
Who's working on it?
1,572
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Rodriguez-Morales AJ7 papers · 2026
Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru.
Papers in Europe PMC - 02Medeiros-Sousa AR5 papers · 2026
Department of Epidemiology, School of Public Health, University of São Paulo, São Paulo 01246-904, Brazil.
Papers in Europe PMC - 03Bonilla-Aldana DK4 papers · 2026
College of Medicine, Korea University, Seoul, Republic of Korea.
Papers in Europe PMC - 04Bonilla-Aldana JL4 papers · 2026
Grupo de Investigación en Ciencias Animales Macagual, Universidad de La Amazonia, Florencia, Caqueta, Colombia.
Papers in Europe PMC - 05Chame M4 papers · 2026
Institutional Platform on Biodiversity and Wildlife Health, Fiocruz, Rio de Janeiro, Brazil.
Papers in Europe PMC - 06Marrelli MT4 papers · 2025
Department of Epidemiology, School of Public Health, University of São Paulo, São Paulo 01246-904, Brazil.
Papers in Europe PMC - 07Pinter A4 papers · 2026
School of Veterinary Medicine and Animal Science (FMVZ)(USP), University of São Paulo, São Paulo, Brazil 05508-270.
Papers in Europe PMC - 08Adegnika AA3 papers · 2026
Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Papers in Europe PMC - 09Becker SC3 papers · 2026
Institute for parasitology to RG for vector associated biodiversity and infection, University of Veterinary Medicine Hanover, Hanover, Germany.
Papers in Europe PMC - 10Borrmann S3 papers · 2026
Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
52
interventional trials for this specific condition
52 interventional trials matched this specific condition name; 8 currently recruiting in our sample.
Data as of 11 September 2026
52 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 97.3th percentile).
low confidence · 97.3th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
52 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT07636551·NOT YET RECRUITING·Baseline Assessment of Skin Resident Memory T Cells in Healthy Unvaccinated Participants
Not reviewed·Conditions: Yellow Fever (Healthy Volunteers) · Biopsy/Methods·Matched via name + MeSH
- NCT06694766·RECRUITING·VAC-SIP-YF (Vaccination- Safety & Immunogenicity During Pregnancy- Yellow Fever)
Not reviewed·Conditions: Yellow Fever Vaccine·Matched via name + MeSH
- NCT05450770·NOT YET RECRUITING·Immunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow Fever Vaccination
Not reviewed·Conditions: HIV Infections · Yellow Fever·Matched via name + MeSH
- NCT06718127·RECRUITING·Description of the Immune Response to Yellow Fever Vaccination
Not reviewed·Conditions: Immunization · Infections·Matched via name + MeSH
- NCT06815835·NOT YET RECRUITING·Non-interference Study of MR and Yellow Fever Vaccines Among Bangladeshi Infants Aged 9-12 Months
Not reviewed·Conditions: Measles · Rubella · Yellow Fever·Matched via name + MeSH
- NCT03132311·RECRUITING·Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals
Not reviewed·Conditions: HIV Infections·Matched via name + MeSH
- NCT05859490·RECRUITING·Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination
Not reviewed·Conditions: Yellow Fever · Immunization; Infection·Matched via name + MeSH
- NCT07103148·RECRUITING·A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population
Not reviewed·Conditions: Yellow Fever Immunization·Matched via name + MeSH
Observational and natural-history studies
13 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT07358910·RECRUITING·Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Not reviewed·Conditions: Dengue · Chikungunya · Zika Virus Infection · Japanese Encephalitis·Matched via name + MeSH
- NCT01244802·ENROLLING BY INVITATION·Characterization of Human Memory Immune Responses to Prior Yellow Fever Vaccination
Not reviewed·Conditions: Yellow Fever Vaccine·Matched via name + MeSH
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 46 · after dedupe 46 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 46 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (46)
- ctis·2025-523476-23-00·Authorised·Tick-Borne Encephalitis (TBE) Remdesivir Efficacy Assessment Trial (TREAT) – A phase 2 proof-of-concept, national, multicenter, randomized, double-blind, placebo-controlled clinical study designed to evaluate the efficacy of remdesivir in adult patients hospitalized for TBE
skipped — LLM skipped (--skip-llm)
- ctis·2024-514154-73-00·Authorised, ongoing·A randomized controlled trial to compare the immunogenicity and skin imprinting of intradermal, subcutaneous and intramuscular yellow fever vaccination
skipped — LLM skipped (--skip-llm)
- ctis·2024-510949-34-00·Cancelled·YF_PROTECT: Prophylactic Treatment with Sofosbuvir for Yellow fever Exemption Circumstances and Travel
skipped — LLM skipped (--skip-llm)
- ctis·2024-511194-29-00·Cancelled·A Phase I, randomized, double-blind, multi-centre, placebo-controlled, dose-escalation study to evaluate the safety, reactogenicity and immunogenicity of AstriVax’ investigational vaccine for the prevention of yellow fever (AVX70120), and of AstriVax’ investigational vaccine for the prevention of rabies (AVX70481), in healthy adults aged 18 to 40 years.
skipped — LLM skipped (--skip-llm)
- ctis·2023-509575-16-00·Authorised, ongoing·Low-Intervention Clinical Trial Evaluating a Novel Cytokine Release Assay for Tick-Borne Encephalitis (TBE) Among Healthy and Immunosuppressed Research Participants
skipped — LLM skipped (--skip-llm)
- ctis·2022-502047-35-00·Expired·Controlled Study of Immunogenicity and Safety of the Investigational vYF Candidate Vaccine in Comparison to Stamaril® in Adults
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN66253408·Recruiting·Clinical study to identify factors that affect the immune response to yellow fever and dengue vaccines
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11357259·Recruiting·An early safety study testing a drug combination given before possible surgery for people with pancreatic cancer that can’t be easily removed yet or hasn’t spread far
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN61739313·No longer recruiting·Evaluating a single intervention product to protect people in both indoor and outdoor contexts from multiple vector-borne diseases.
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15551486·Recruiting·Ibuprofen for menstrual cramps
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN61885353·No longer recruiting·Scaling bundled health services in rural Sierra Leone
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN49327404·Recruiting·Deconstructing the protective immunity of yellow fever virus 17D to inform flavivirus vaccine design, Yellow4FLAVI – Colombian Component
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN26330175·Recruiting·Understanding and managing fevers from infections spread by animals
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN98882766·Recruiting·A study of arbovirus-infected individuals that have travelled from outside of the UK
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN99739590·No longer recruiting·First-in-human study evaluating the effect of various doses of ODM-212 in subjects with selected advanced solid tumours
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16573769·No longer recruiting·DOMENICA: Randomized phase III trial in MMR deficient endometrial cancer patients comparing chemotherapy alone versus dostarlimab in a first-line advanced/metastatic setting
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN85988131·No longer recruiting·Understanding how the immune system responds to repeated malaria infections
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN57717892·No longer recruiting·Safety and immune response of the malaria vaccine, R21/Matrix-M™, in Thai adults
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN60488657·No longer recruiting·New 6-in-1 vaccine study to guide UK vaccine policy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17974967·No longer recruiting·Creating and studying a group of yellow fever-vaccinated individuals to discover factors affecting the immune response to vaccination and acute viral infections
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15802039·No longer recruiting·Effectiveness of corticosteroids in controlling complications after bichectomy surgery
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN18152519·No longer recruiting·Comparing vildagliptin/metformin 50 mg/1000 mg film-coated tablets (Sensityn®) vs Galvusmet® 50 mg/1000 mg film-coated tablets in healthy adults, under fed conditions
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15021247·No longer recruiting·Phase II study for the treatment of recurrent and/or metastatic human papillomavirus (HPV16)-associated head and neck cancer
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN59811905·No longer recruiting·Using parents and health workers to increase the number of children who received all the recommended childhood vaccinations without any delay in the communities of Ebonyi state, Nigeria
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14236594·No longer recruiting·Chinese herbal medicine Shufeng Jiedu capsule for patients with mild to moderate COVID-19
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Yellow fever — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Yellow fever" OR "Bronze John" OR "Yellow Jack" OR "Yellow fever Virus infection" OR "Yellow fever virus infectious disease" OR "sylvatic yellow fever"
MeSH descriptor terms unioned into the query: Yellow Fever
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Yellow fever" OR "Bronze John" OR "Yellow Jack" OR "Yellow fever Virus infection" OR "Yellow fever virus infectious disease" OR "sylvatic yellow fever"
Interventional trials matched via: both (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 52 interventional · 13 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase, mesh; with hits: phrase, mesh
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: YF; Yellow fever virus caused disease or disorder; Yellow fever virus disease or disorder
Confidence reasoning
- Preferred label is multi-word and distinctive
- 1 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
- Publication count (70238) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-27T06:21:32.229Z
